Evidence map›Paper›PMID 37384904›Full record

ArticleACS sensors2023

Electrochemical Immunosensor for Ultra-Low Detection of Human Papillomavirus Biomarker for Cervical Cancer.

Siwaphiwe Peteni, Okoroike C Ozoemena, Tobile Khawula, Aderemi B Haruna, Frankie J Rawson, Leshweni J Shai, Oluwafunmilola Ola, Kenneth I Ozoemena

Open access · hybridAbstract read
In one paragraph

Article in ACS sensors, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Siwaphiwe PeteniMolecular Science Institute, School of Chemistry, University of the Witwatersrand, Johannesburg 2050, South Africa.
Okoroike C OzoemenaMolecular Science Institute, School of Chemistry, University of the Witwatersrand, Johannesburg 2050, South Africa.
Tobile KhawulaMolecular Science Institute, School of Chemistry, University of the Witwatersrand, Johannesburg 2050, South Africa.
Aderemi B HarunaMolecular Science Institute, School of Chemistry, University of the Witwatersrand, Johannesburg 2050, South Africa.
Frankie J RawsonSchool of Pharmacy, Biodiscovery Institute University of Nottingham, Nottingham NG7 2RD, U.K.ORCID 0000-0002-4872-8928
Leshweni J ShaiDepartment of Biomedical Sciences, Tshwane University of Technology, Pretoria 0001, South Africa.
Oluwafunmilola OlaAdvanced Materials Group, Faculty of Engineering, The University of Nottingham, Nottingham NG7 2RD, U.K.
Kenneth I OzoemenaMolecular Science Institute, School of Chemistry, University of the Witwatersrand, Johannesburg 2050, South Africa.ORCID 0000-0001-7107-7003
University of the Witwatersrand · ZAUniversity of Nottingham · GBTshwane University of Technology · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human papillomavirus (HPV) is the causative agent for cervical cancer. Of the various types of HPV, the high-risk HPV-16 type is the most important antigenic high-risk HPV. In this work, the antigenic HPV-16 L1 peptide was immobilized on a glassy carbon electrode and used to detect several concentrations of the anti-HPV-16 L1 antibody, and vice versa. Two electrode platforms were used: onion-like carbon (OLC) and its polyacrylonitrile (OLC-PAN) composites. Both platforms gave a wide linear concentration range (1.95 fg/mL to 6.25 ng/mL), excellent sensitivity (>5.2 μA/log ([HPV-16 L1, fg/mL]), and extra-ordinarily low limit of detection (LoD) of 1.83 fg/mL (32.7 aM) and 0.61 fg/mL (10.9 aM) for OLC-PAN and OLC-based immunosensors, respectively. OLC-PAN modified with the HPV-16 L1 protein showed low LoD for the HPV-16 L1 antibody (2.54 fg/mL, i.e., 45.36 aM), proving its potential use for screening purposes. The specificity of detection was proven with the anti-ovalbumin antibody (anti-OVA) and native ovalbumin protein (OVA). An immobilized antigenic HPV-16 L1 peptide showed insignificant interaction with anti-OVA in contrast with the excellent interaction with anti-HPV-16 L1 antibody, thus proving high specificity. The application of the immunosensor as a potential point-of-care (PoC) diagnostic device was investigated with screen-printed carbon electrodes, which detected ultra-low (ca. 0.7 fg/mL ≈ 12.5 aM) and high (ca. 12 μg/mL ≈ 0.21 μM) concentrations. This study represents the lowest LoD reported for HPV-16 L1. It opens the door for further investigation with other electrode platforms and realization of PoC diagnostic devices for screening and testing of HPV biomarkers for cervical cancer.

Indexed as

Biosensing TechniquesUterine Cervical NeoplasmsBiomarkersCarbonFemaleHuman Papillomavirus VirusesHumansImmunoassayBiomarkersCarbonantigenic HPV-16 L1 peptideanti-HPV-16 L1 antibodyanti-ovalbumin antibodyonion-like carbonovalbumin proteinpolyacrylonitrile fiberultra-low detection

Identifiers

PMID37384904
PMCPMC10391710
OpenAlexW4382601520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.